In the Oncomine database, we found that the expression levels of CXCL1/2/3/4/5/6/7/8/9/10/11/16/17 were significantly upregulated while that of CXCL12/13/14 were downregulated in CRC patients. The gene discussed is CXCL12; the disease is colorectal carcinoma.